IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The ability to tolerate Candida albicans, a human commensal of the gastrointestinal tract and vagina, implicates that host defense mechanisms of resistance and tolerance cooperate to limit fungal burden and inflammation at the different body sites. We evaluated resistance and tolerance to the fungus in experimental and human vulvovaginal candidiasis (VVC) as well as in recurrent VVC (RVVC). Resistance and tolerance mechanisms were both activated in murine VVC, involving IL-22 and IL-10-producing regulatory T cells, respectively, with a major contribution by the enzyme indoleamine 2,3-dioxygenase 1 (IDO1). IDO1 was responsible for the production of tolerogenic kynurenines, such that replacement therapy with kynurenines restored immunoprotection to VVC. In humans, two functional genetic variants in IL22 and IDO1 genes were found to be associated with heightened resistance to RVVC, and they correlated with increased local expression of IL-22, IDO1 and kynurenines. Thus, IL-22 and IDO1 are crucial in balancing resistance with tolerance to Candida, their deficiencies are risk factors for RVVC, and targeting tolerance via therapeutic kynurenines may benefit patients with RVVC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341 · cited 1×
“Indoleamine 2,3-dioxygenase 1 (IDO1), the rate-limiting enzyme in tryptophan degradation along the kynurenine pathway [33], is a master regulator of antifungal tolerance at mucosal surfaces [34].”
BackgroundRomani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Self-citationChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“Mutations in IL17F, IL17R and DECTIN1 in patients with chronic mucocutaneous candidiasis, as well as neutralizing autoantibodies against IL-17 and IL-22 in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, directly impair IL-17 and IL-22 immunity [47,52–54].”
BackgroundA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“Mutations in IL17F, IL17R and DECTIN1 in patients with chronic mucocutaneous candidiasis, as well as neutralizing autoantibodies against IL-17 and IL-22 in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, directly impair IL-17 and IL-22 immunity [47,52–54].”
BackgroundSchneider, D. S., & Ayres, J. S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2432 · Cited by 783
Human dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · cited 2×
“Thus, in addition to functional polymorphisms in genes coding for mannose-binding lectin [55–57], IL-4 [58], and the inflammasome component NALP3 [59] in predisposing to RVVC, our study identified an IL22 variant that is associated with a decreased risk for RVVC and is consistent with the findings obtained relative to…”
BackgroundResultDefective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., et al. (2008) · Nature · doi:10.1038/nature06471 · Cited by 535
Self-citationCunha, C., Di Ianni, M., Bozza, S., Giovannini, G., Zagarella, S., Zelante, T., D'Angelo, C., Pierini, A., Pitzurra, L., Falzetti, F., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279307 · Cited by 286 · cited 1×
“Genotyping was performed as previously described [68,69].”
Self-citationIL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.22 · Cited by 265
Self-citationCandida vaginitis: Self-Reported Incidence and Associated Costs
Foxman, B., Barlow, R., Dʼarcy, H., Gillespie, B., & Sobel, J. D. (2000) · Sexually Transmitted Diseases · doi:10.1097/00007435-200004000-00009 · Cited by 158 · cited 1×
“In addition to the associated costs that are very high [64], there is concern that repeated treatments might induce drug resistance.”
Background
Cited by
The mycobiota: interactions between commensal fungi and the host immune system
Underhill, D. M., & Iliev, I. D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3684 · Cited by 695
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2022) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 477
Fungal dysbiosis: immunity and interactions at mucosal barriers
Iliev, I. D., & Leonardi, I. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.55 · Cited by 393
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Gut Mycobiota in Immunity and Inflammatory Disease
Li, X. V., Leonardi, I., & Iliev, I. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.023 · Cited by 246
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
Rosati, D., Bruno, M., Jaeger, M., ten Oever, J., & Netea, M. G. (2020) · Microorganisms · doi:10.3390/microorganisms8020144 · Cited by 206
Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome
Bruno, V. M., Shetty, A. C., Yano, J., Fidel, P. L., Noverr, M. C., & Peters, B. M. (2015) · mBio · doi:10.1128/mbio.00182-15 · Cited by 155
Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street
Underhill, D. M., & Pearlman, E. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.023 · Cited by 130
Borghi, M., Pariano, M., Solito, V., Puccetti, M., Bellet, M. M., Stincardini, C., Renga, G., Vacca, C., Sellitto, F., Mosci, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02364 · Cited by 63
“IL-22-producing ILC3s were indeed present in the vagina and expanded in VVC in wild-type mice, but not in IL-22-deficient mice, while IL-22 production was significantly decreased in AhR-deficient mice, these findings clearly demonstrating that IL-22 was produced by vaginal ILC3s via AhR (22).”
BackgroundSelf-citationThe cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
Romani, L., Zelante, T., Palmieri, M., Napolioni, V., Picciolini, M., Velardi, A., Aversa, F., & Puccetti, P. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0464-2 · Cited by 47
Self-citationThe microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases
Gonçalves, S. M., Lagrou, K., Duarte-Oliveira, C., Maertens, J. A., Cunha, C., & Carvalho, A. (2017) · Virulence · doi:10.1080/21505594.2016.1257458 · Cited by 32
“in the vaginal microbiome and functional genetic variants affecting these pathways were associated with the development of recurrent vulvovaginal candidiasis.(95) Whether tryptophan metabolites also display systemic effects remains to be elucidated.”
BackgroundSelf-citationNaglik, J. R. (2014) · New Journal of Science · doi:10.1155/2014/390241 · Cited by 29
Prospects for adoptive T-cell therapy for invasive fungal disease
Castellano-Gonzalez, G., Clancy, L. E., & Gottlieb, D. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000403 · Cited by 22
Colonization and effector functions of innate lymphoid cells in mucosal tissues
Kim, M., & Kim, C. H. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.06.005 · Cited by 16
“ILC3 also produce IL-22 during Candida infection [97].”
BackgroundTian, J.-Y., Yang, Y.-G., Chen, S., Teng, Y., & Li, X.-Z. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.104893 · Cited by 13
Metadata
- Authors
- De Luca, A., Carvalho, A., Cunha, C., Iannitti, R. G., Pitzurra, L., Giovannini, G., Mencacci, A., Bartolommei, L., Moretti, S., Massi-Benedetti, C., Fuchs, D., De Bernardis, F., Puccetti, P., & Romani, L.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-11
- Volume
- 9
- Issue
- 7
- Pages
- e1003486
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1980201642
- Cited by
- 122
- References
- 11
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.